🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BHV
$BHVN
🔒 US EquitiesBiohaven Ltd.
AVG HISTORICAL GAP
-0.66%
MAX GAP RECORD
-6.25%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BHVN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BHVN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (16:00)) |
-6.25%
|
| Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE) |
-3.71%
|
| May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE) |
+0.82%
|
| Mar 02, 2026 Earnings Release 2026-03-02 (AFTER CLOSE) |
-3.22%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
+2.30%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (BEFORE OPEN) |
-2.99%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
+0.92%
|
| Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN) |
-0.62%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.9%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (6)
📖 Intelligence Summary
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗